Farnaz Khajeh-Rahimi

Farnaz Khajeh-Rahimi

Auto-generated profile, based on publicly available information

Farnaz Khajeh-Rahimi

Nuclear Medicine Department, Medical School, Shiraz University of Medical Science, Shiraz, Iran

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Indian Journal of Nuclear Medicine
Verified
Journal Article
Open access
MHMahdi Haghighatafshar
Mahdi Haghighatafshar
FKFarnaz Khajehrahimi
Farnaz Khajehrahimi
There are a few case reports of hiatal hernia demonstrating thoracic uptake on I-131 scintigraphy. In this case, high thyroglobulin levels in combination with misinterpretation of I-131 uptake in the mediastinum, leaded to mismanagement of the patient. Here we present a case of focal I-131 uptake within a hiatal hernia initially mimicking an isolated mediastinal metastasis. There are many potential causes of false-positive I-131 scan result. In this case, adjunctive chest computed tomography and gastroesophageal barium study helped to elucidate the true nature of this I-131 uptake. False-positive findings may be caused by a wide variety of nonthyroidal carcinomas, which can concentrate radioiodine or from skin contamination. Several organs, such as the gastric, salivary glands, renal cyst, pericardial effusion, and ovarian can accumulate I-131. It should be borne in mind as a potential source of false-positive whole-body I-131 imaging.

1 June 2019 in Cancer Biotherapy and Radiopharmaceuticals
Verified
Journal Article
Closed access
MAMehrosadat Alavi
Mehrosadat Alavi
FKFarnaz Khajeh-Rahimi
Farnaz Khajeh-Rahimi
HYHassan Yousefnia
Hassan Yousefnia
MMMohammad Mohammadianpanah
Mohammad Mohammadianpanah
SZSamaneh Zolghadri
Samaneh Zolghadri
MGMohammad Ghannadi-Maragheh
Mohammad Ghannadi-Maragheh
Background: Production of effective, low-cost, and efficient radiopharmaceuticals is an important task and requires further research and clinical studies. In this clinical trial, safety and efficacy of Lu-177/Sm-153 ethylenediamine tetramethylene phosphonic acid (EDTMP) cocktail has been evaluated for pain relief of bone metastases. Materials and Methods: Twenty-five patients with the mean age of 55.5 ± 15.8 years participated in this study. Patients received a total dose of 37 MBq/kg. Pain and performance assessments were followed using a Brief Pain Inventory form. Complete blood count and renal and liver function tests were also performed up to 12 weeks postadministration. Results: Eighteen patients (72%) demonstrated complete pain relief (relief = 100%) and approximately all patients (96%) experienced significant improvement in their quality of life. No grade IV hematological toxicity was observed during the 12-week follow-up period, and grade III toxicity was seen in 1 patient only. In addition, no abnormalities were seen in renal and liver function during the follow-up period. Conclusions: There were no considerable complications after administration of Lu-177/Sm-153 EDTMP; this cocktail seems to be a safe and effective treatment for bone pain palliation in patients with skeletal metastases and improves the quality of life.

6 July 2018 in Journal of Biomedical Physics and Engineering
Verified
Journal Article
Open access
PDF file
MAM S Alavi
M S Alavi
MOM A Okhovat
M A Okhovat
MAMohammad Atefi
Mohammad Atefi
FRF Khajeh Rahimi
F Khajeh Rahimi
SMSmj Mortazavi
Smj Mortazavi
FEF Ebadi
F Ebadi
Purpose: With increasing the usage of myocardial perfusion imaging (MPI) for the diagnosis of ischemic heart disease, we aimed to evaluate the side effects of low-dose radiation induced by this technique on blood elements, especially proteins and liver function factors.Materials and Methods: 40 eligible patients (Mean age: 54.62±10.35, 22 female and 18 male), who had referred to the nuclear medicine department for MPI from May till August 2014, were enrolled in the study. A blood sample was taken from each patient just before and 24 hours after the injection of 740Mbq of Tecnetium-99m Methoxy isobutyl isonitrile (99mTc-MIBI) in the rest phase of the MPI in a reference medical laboratory; blood tests included total protein (TP), albumin (Alb), globulin (Glo), aspartate aminotransferase (AST), alanine transaminase(ALT), alkaline phosphatase (ALP), direct bilirubin (D.Bili), total bilirubin (T.Bili),serum iron (SI), total iron bounding capacity (TIBC), Albumin globulin ratioA/G ratio), and complete blood count (CBC).Results: Injection of 740Mbq99mTc-MIBI caused a significant increase in serum levels of AST (p= 0.001), ALT (p= 0.001), SI(p= 0.030), TIBC (p= 0.003) and A/G Ratio (p= 0.020). However, following radiotracer injection, a significant decrease was noted in the serum levels of TP (p= 0.002), Alb (p= 0.014), Glo(p= 0.002), ALP(p= 0.001), D.Bili (p= 0.003) and T.Bili(p= 0.000).Conclusion: Due to increased usage of MPI, our data highlights the importance of monitoring the clinical and paraclinical effects of the procedure on vital organs and physiological pathways to reduce their adverse effects.